Jefferies analyst Eun Yang downgraded Biomea Fusion to Hold from Buy.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on BMEA:
- Jefferies Reconsiders, BMEA Plummets after Sour Diabetes Drug Data
- Biomea Soars on Promising Phase 2 Data in Type 2 Diabetes
- Biomea Fusion price target raised to $45 from $40 at Piper Sandler
- 3 Best Stocks to Buy Now, 6/26/2023, According to Top Analysts
- JPMorgan ups Biomea Fusion target, adds to Analyst Focus List